Summary
To elucidate the underlying mechanism of nivalenol toxicity, we treated human promyelocytic leukemia HL60 cells with nivalenol for 24 h and investigated the toxin's effects on cell viability and interleukin (IL)-8 secretion. Whereas exposure to 1 µg/ml nivalenol led to slight morphologic damage, that after treatment with 3 or 10 µg/ml nivalenol was pronounced.
In 5-bromo-2-deoxyuridine (BrdU) incorporation assays of the rate of cell proliferation, the mean 50 % inhibitory concentration (IC50) of nivalenol was 0.16 µg/ml. The effect of nivalenol on mitochondrial succinic dehydrogenase activity was examined using the water-soluble tetrazolium-8 assay, in which the mean IC50 was 0.40 µg/ml. The activity of lactate dehydrogenase (LDH) released from the cytoplasm was very low, even at 10 µg/ml nivalenol, indicating that although treated cells had extensive morphologic damage, they did not burst. We used BrdU incorporation (the most sensitive indicator of cell viability) to assess the effect of 1,2bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetraacetoxymethyl ester (BAPTA-AM), which chelates intracellular calcium ion, on nivalenol toxicity. BrdU incorporation after concomitant treatment with nivalenol and BAPTA-AM was higher than that after treatment with nivalenol alone, indicating that the cytotoxicity of nivalenol is dependent in part on intracellular calcium ion. Further, the media of nivalenol-treated cells contained substantial amounts of IL-8, suggesting that this cytokine contributes to the nivalenol-caused pathologic phenomena. cytotoxicity to the human promyelocyte-derived cell line HL60.
Materials and methods

Chemicals and cells
Nivalenol was purchased from Sigma-Aldrich Corporation (St. Louis, MO, USA Morphologic study Approximately 4 10 5 cells in 2 ml of medium with nivalenol were cultured in each well of a 6-well culture plate for 24 h, then examined under a microscope.
Assessment of cell viability
The methods used to measure 5-bromo-2-deoxyuridine (BrdU) incorporation during DNA synthesis and mitochondrial succinic dehydrogenase activity (WST-8 assay) were described previously 5) . Approximately 5 10 3 cells (BrdU assay) or 2 10 4 cells (WST-8 assay) in 100 µl medium with chemicals were placed in each well of a 96-well microtiter plate and incubated for 24 h.
Cytoplasmic lactate dehydrogenase (LDH) is leaked to the culture medium after cell death and subsequent rupture of the cell membrane. LDH activity in the culture supernatant was measured as follows 6) . Approximately 1 10 5 cells in 0.5 ml medium containing either nivalenol or 0.1 % Tween 20
were cultured for 24 h in each well of a 24-well culture plate. Media then were collected and centrifuged at 5,000 g for 5 min to remove cells and debris, and supernatants were subjected to LDH assay. A 30-µl aliquot of supernatant was added to 200 µl Lactate Dehydrogenase CII-TestWAKO color solution. After 30 min incubation at 37 , 2 ml 0.1 N hydrochloric acid was added to stop the reaction, and then optical densities at 560 nm were read. We assumed the activities of the Tween 20treated controls to be 100 %, and the activities of samples were expressed as relative percentages. 
Determination of interleukin (IL) -8 levels
Approximately 1 10 5 cells in 0.5 ml medium containing nivalenol were cultured for 24 h in each well of a 24-well culture plate. Media were collected and centrifuged at 5,000 g for 5 min to remove cells and debris, and the levels of IL-8 in the culture supernatants were quantified using the Quantikine Human IL-8 Immunoassay kit (R&D Systems, Inc., Minneapolis, MN, USA) according to the manufacturer's recommended procedure.
Statistics
Data are expressed as mean standard deviation. Logarithmically transformed data were statistically analyzed. Differences between groups were analyzed using Tukey's test or Dunnett's test. A P value of < 0.05 was considered to be significant.
Results and Discussion
At 1 µg/ml (3.2 µM) nivalenol ( Fig. 2B ), slight morphologic damage was apparent, and most of the cells looked sound. In contrast, cells treated with 3 or 10 µg/ml nivalenol clearly were damaged ( Fig. 2C, D) , and more than half of the cells were dead under these experimental conditions. Using morphologic damage as a criterion, the 50 % cytotoxic concentration (CC50) of nivalenol is between 1 and 3 µg/ml.
It has been reported that nivalenol inhibits cell proliferation 7-10) , therefore, we measured BrdU incorporation to determine the rate of cell proliferation. We repeated the experiment 4 times, and the mean value of 50 % inhibitory concentration (IC50) of nivalenol was 0.16 µg/ml (Table 1) Triplicate WST-8 assays indicated that the mean IC50 of nivalenol was 0.40 µg/ml (Table 1) . The effect of nivalenol on mitochondrial succinic dehydrogenase activity has been examined using MTT assay 8, 11, 12) , which determines enzyme activities by the same principle as WST-8 assay, but the results of these previous studies vary. Minervini et al. reported that the IC50 of nivalenol in K562 cells was 0.5 µM (0.16 µg/ml) 8) . However, Yang et al. did not observe any effect of nivalenol on RAW 364.7 and U937 cells at concentrations of 10 µg/ml or lower 11) , whereas according to Sugita-Konishi and Pestka, the IC50 of nivalenol in U937 cells was approximately 1 µg/ml 12) . It is likely that these discrepancies are due to differences in experimental conditions, including cell type.
We measured supernatant LDH activity 3 times. At 10 µg/ml nivalenol or lower, supernatant LDH activity was less than 50 % that in Tween 20-treated samples (CC50; Table 1 ) under our experimental conditions. Although HL60 cells treated with 10 µg/ml nivalenol showed profound morphologic change (Fig. 2D) , presumably the cells did not burst. Because nivalenol reportedly induces apoptosis in HL60 cells 13) , we considered that the marked nivalenol-caused morphologic change was due to apoptosis. Minervini et al. used trypan blue exclusion test, another test that is based on breakage of cell membrane 8) , to monitor cell viability. They found that 80 % of K562 cells were viable even at 25.0 µg/ml nivalenol 8) -a finding that is consistent with our result regarding cytoplasmic LDH activity.
Because it is reported that the intracellular calcium ion chelator BAPTA-AM inhibited trichothecene mycotoxin T-2 toxin-induced apoptosis in HL60 cells 14) , we investigated the chelator's effect on nivalenol toxicity in these cells. We chose BrdU incorporation for this purpose, because in our hands, this test was the most sensitive measure of cell viability (Fig. 2, Table 1 ). Treatment with BAPTA-AM alone slightly hindered cell proliferation (78.5 % that of vehicle-treated control samples; Table 2 ). Cell proliferation after concomitant treatment with nivalenol and BAPTA-AM (17.1 %) was greater than that after treatment with nivalenol alone (10.3 %), and the difference between these Mycotoxins 68 treatments was statistically significant (P < 0.05; Table 2 ). That BAPTA-AM moderately impaired the cyotoxicity of nivalenol indicates that this effect is partly dependent on intracellular calcium ion. We also tested other calcium modulators, including verapamil (calcium channel blocker), ethylene glycolbis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA; extracellular calcium ion chelator), and K-252a (inhibitor of calmodulin kinase II and protein kinase C), but they all lacked significant effect on nivalenol-caused inhibition of cell proliferation (data not shown).
The proinflammatory cytokine IL-8 is known to be indispensable to the development of diverse pathologic phenomena; accordingly, we investigated whether nivalenol induces IL-8 secretion from HL60 cells. Whereas treatment with 0.1 µg/ml nivalenol decreased IL-8 secretion slightly, 0.3 µg/ml and higher concentrations increased IL-8 secretion from HL60 cells ( Table 3) . The values from samples treated with 3 or 10 µg/ml nivalenol were smaller than that from cells exposed to 1 µg/ml nivalenol, probably because of damage to the cells (Fig. 2C, D) . Sugita-Konishi and Pestka also found that nivalenol induced IL-8 secretion from U937 cells 12) , consistent with the possibility that IL-8 is responsible for nivalenol-caused pathologic phenomena.
In the present study, we demonstrated that intracellular calcium ion plays a role in nivalenolcaused cytotoxicity in HL60 cells. We also showed that nivalenol induces IL-8 secretion from HL60 cells. However, further studies are needed to elucidate the detailed mechanism of cytotoxicity and IL-8 secretion evoked by nivalenol. 185-194 (1968) Minervini, F., Fornelli, F., Flynn, K.M.: Toxicol. in vitro, 18, 21-28 (2004) Thuvander, A., Wikman, C., Gadhasson, I.: Food Chem. Toxicol., 37, 639-648 ( (2001) Ueno, Y., Umemori, K., Niimi, E., Tanuma, S., Nagata, S., Sugamata, M., Ihara, T., Sekijima, M., Kawai, K., Ueno, I., Tashiro, F.: Nat. Toxins, 3, 129-137 (1995) Yoshino, N., Takizawa, M., Akiba, H., Okumura, H., Tashiro 
